Virus purification highlights the high susceptibility of SARS-CoV-2 to a chlorine-based disinfectant, chlorous acid

PLoS One. 2023 Jul 14;18(7):e0288634. doi: 10.1371/journal.pone.0288634. eCollection 2023.

Abstract

Chlorous acid water (HClO2) is known for its antimicrobial activity. In this study, we attempted to accurately assess the ability of chlorous acid water to inactivate SARS-CoV-2. When using cell culture supernatants of infected cells as the test virus, the 99% inactivation concentration (IC99) for the SARS-CoV-2 D614G variant, as well as the Delta and Omicron variants, was approximately 10ppm of free chlorine concentration with a reaction time of 10 minutes. On the other hand, in experiments using a more purified virus, the IC99 of chlorous acid water was 0.41-0.74ppm with a reaction time of 1 minute, showing a strong inactivation capacity over 200 times. With sodium hypochlorite water, the IC99 was 0.54ppm, confirming that these chlorine compounds have a potent inactivation effect against SARS-CoV-2. However, it became clear that when using cell culture supernatants of infected cells as the test virus, the effect is masked by impurities such as amino acids contained therein. Also, when proteins (0.5% polypeptone, or 0.3% BSA + 0.3% sheep red blood cells, or 5% FBS) were added to the purified virus, the IC99 values became high, ranging from 5.3 to 76ppm with a reaction time of 10 minutes, significantly reducing the effect. However, considering that the usual usage concentration is 200ppm, it was shown that chlorous acid water can still exert sufficient disinfection effects even in the presence of proteins. Further research is needed to confirm the practical applications and effects of chlorous acid water, but it has the potential to be an important tool for preventing the spread of SARS-CoV-2.

MeSH terms

  • Animals
  • COVID-19*
  • Chlorine / pharmacology
  • Disinfectants* / pharmacology
  • Humans
  • SARS-CoV-2
  • Sheep
  • Viruses*
  • Water

Substances

  • Disinfectants
  • chlorous acid
  • Chlorine
  • Water

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

This study was supported by Research Grants for COVID-19 from AMED, Japan under Grant Numbers JP20he0622011 and JP21fk0108558 (to T. S.), and JP20fk0108453 and JP21fk0108550 (to J. T. and T. S.), a grant from the Government-Academia Collaboration of Hiroshima Prefecture (to J. T. and T. S.), and a research grant from JST SPRING, under a grant number JPMJSP2132 (to B. L-A. and M. K.). This work was also supported by Sumitomo-Mitsui Banking Corporation COVID-19 Research Fund (to T. S.), and the Otsuka Toshimi Scholarship Foundation (to T. Na.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.